Published June 22, 2022
| Version v1
Journal article
Open
Radiopharmaceutical Supply Disruptions and the Use of 99mTc-99 Hydroxymethylene Diphosphonate as an Alternative to 99mTc-Pyrophosphate for the Diagnosis of Transthyretin Cardiac Amyloidosis: An ASNC Information Statement
Creators
- 1. Yale School of Medicine, New Haven, CT
- 2. Columbia University Irving Medical Center and NewYork-Presbyterian Hospital, New York, NY
Description
Amid pyrophosphate shortage, the American Society of Nuclear Cardiology issues an information statement on how to use HMDP as an alternative radiopharmaceutical in cardiac amyloidosis imaging. Early diagnosis of ATTR cardiac amyloidosis must not be jeopardized.
Files
Files
(574.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:855ddfa6439b6891b73fd5efb0ad7cb0
|
574.3 kB | Download |